Insulinemic and Inflammatory Dietary Patterns and Breast Cancer Outcomes: Role of the PI3K/AKT/MTOR Pathway Among Black Women
In a study of Black women with breast cancer, a low-insulinemic dietary pattern (higher rEDIH) was associated with reduced odds of p-P70S6K-positive tumors and lower mortality among those with PI3K/AKT/MTOR pathway activation, suggesting that mechanistically targeted dietary indices may better predict breast cancer outcomes than overall diet quality.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
Breast cancer remains a leading health challenge for women, with a particularly stark reality for Black women in the United States, who face significantly higher rates of death from the disease compared to their White counterparts. While medical treatments have improved survival rates overall, the gap in outcomes persists, driven in part by factors that can be changed, such as diet and body weight. Scientists have long suspected that what we eat influences how cancer behaves inside the body, not just by affecting weight, but by altering the chemical signals that tell cells when to grow and when to stop. One specific set of these signals, known as the PI3K/AKT/MTOR pathway, acts like a master switch for cell growth and survival. When this switch gets stuck in the "on" position, it can drive tumors to grow aggressively and resist treatment. Researchers are now asking whether the food on a person's plate can help turn that switch back down, potentially offering a way to improve survival for those with the most aggressive forms of the disease.
A team of researchers set out to investigate this question by looking closely at the diets and tumor tissues of nearly 400 Black women who had been diagnosed with breast cancer. These women were part of a long-term health study that tracked their habits and health outcomes over many years. Before their diagnosis, the women had filled out detailed questionnaires about what they typically ate over the previous year. The researchers used these answers to calculate three different scores for each woman's diet. One score measured how likely a diet was to cause high levels of insulin in the body, a hormone that can fuel cancer growth. Another score measured how likely a diet was to cause inflammation, which is the body's natural response to injury but can become harmful when it is constant. The third score was a general measure of overall diet quality, based on how well a diet followed standard healthy eating guidelines.
Once the women had their tumors surgically removed, the researchers examined the tissue under a microscope to see if the cancer cells showed signs of the overactive growth switch mentioned earlier. They looked for specific proteins that act as markers for this pathway, essentially checking if the cancer cells were using this high-speed growth engine. The team then compared the women's dietary scores with the presence of these markers and tracked who survived and who did not over the following years.
The results pointed to a clear connection between a diet that keeps insulin levels low and better outcomes, but only for a specific group of women. The researchers found that women who ate a diet lower in insulin-spiking foods were less likely to have tumors that showed high levels of one of the key growth markers, specifically a protein called p-P70S6K. More importantly, among the women whose tumors did show signs of this overactive growth pathway, those who ate a low-insulin diet had a significantly lower risk of dying from breast cancer or from any cause. For every step up in the quality of this low-insulin diet, the risk of death dropped noticeably. This suggests that for women whose cancers are driven by this specific biological pathway, eating to keep insulin levels low might act as a powerful support to medical treatment.
In contrast, the study found that the other two dietary measures did not tell the same story. A diet score focused on reducing inflammation did not show a strong link to the presence of the growth markers in the tumors, nor did it consistently lower the risk of death, although there were some hints of a benefit in specific subgroups. Similarly, the general score for overall healthy eating, which includes guidelines on fruits, vegetables, and whole grains, showed no clear connection to the tumor markers or to survival rates in this group. This distinction is crucial because it suggests that a broad approach to "healthy eating" might miss the specific biological mechanisms that drive aggressive cancer in some patients.
The study also looked at whether these findings held up when the data was analyzed in different ways to ensure the results were not a fluke. The patterns remained consistent, reinforcing the idea that the link between low-insulin diets and survival is real. The researchers noted that while the study was limited by its size and the fact that it focused on one specific population, the findings are significant enough to warrant further attention. They suggest that future medical strategies could move beyond a one-size-fits-all approach to nutrition. Instead, doctors might one day be able to look at a patient's tumor, see if it is driven by this specific growth pathway, and recommend a specific dietary pattern designed to calm that pathway down. For now, the work highlights that what we eat does more than just fill us up; it can interact with the very machinery of our cells, and for Black women with breast cancer, choosing foods that keep insulin levels in check may be a vital part of the fight for survival.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.